1MEREDITH PA, ELLIOTT HL. FDA guidelines on trough:peak ratios in the evalu ation ofantihypertensive agents [J]. J Cardiovasc Pharmacol,1994,23 Suppl 5 : S26-S30.
2PARATI G, OMBONI S, RIZZONI D. The smoothness index: a new, reproducible andclinically relevant measure of the homogeneity of the blood pressure reducti on withtreatment for hypertension[J]. J Hypertens,1998, 16(11): 1685-1691.
3GROPPELLI A, OMBONI S, PARATI G. Evaluation of noninvasive blood pressuremonitoring devices spacelabs 90202 and 90207 versus resting and ambulatory 24-h ourintra-arterial blood pressure[J]. Hypertension,1992,20(2):227-232.
4OMBONI S, PARATI G, ZANCHETTI A. Calculation of trough:peak ratio of antihypertensive treatment from ambulatory blood pressure: methodological aspects[J ]. JHypertens,1995,13(10):1105-1112.
5BLAND JM, ALTMAN DG. Statistical methods for assessing agreement between t womethods of clinical measurement[J]. Lancet, 1986,1(8476):307-310.
6MACCHIARULO C, PIERI R, MITOLO DC. Antihypertensive effects of six calciumantagonists: evidence from fourier analysis of 24-hour ambulatory blood pressu rerecordings. Curr Ther Res Clin Exp, 2001,62(4):236-253.
7STAESSEN JA, THIJS L, MANCIA G. Clinical trials with ambulatory blood pres su remonitoring : fewer patients needed? Syst-Eur Investigators [J]. Lancet ,1994,344(8936):1552-1556.
8ZANNAD F, BERNAUD CM, FAY R. Double-blind, randomized, multicentre compar iso n ofthe effects of amlodipine and perindopril on 24h therapeutic coverage and b eyond inpatients with mild to moderate hypertension [J]. J Hypertens,1999,17( 1):137-146.
